Home
Independent Director
Independent Director
Vice Chairman & M.D.
Whole-time Director
Chairman & Independent Directo
NSE: AUROPHARMA
Share Price
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
20 Dec 2024 | 1240.7 | 1254 | 1274.7 | 1235.15 |
19 Dec 2024 | 1255.4 | 1240.05 | 1273.95 | 1230.95 |
18 Dec 2024 | 1247.85 | 1211 | 1256.3 | 1202.7 |
17 Dec 2024 | 1213.45 | 1246.75 | 1248.6 | 1211 |
16 Dec 2024 | 1245 | 1231.4 | 1247.95 | 1220.45 |
13 Dec 2024 | 1207.95 | 1215.15 | 1216.4 | 1173.25 |
12 Dec 2024 | 1215.15 | 1236.35 | 1236.35 | 1211 |
11 Dec 2024 | 1225.7 | 1239.65 | 1240.5 | 1224 |
10 Dec 2024 | 1238.05 | 1246.75 | 1246.75 | 1231.75 |
09 Dec 2024 | 1239.4 | 1249 | 1258.6 | 1237.35 |
Date | Price (₹) |
---|---|
20 Dec 2024 | 1240.7 |
19 Dec 2024 | 1255.4 |
18 Dec 2024 | 1247.85 |
17 Dec 2024 | 1213.45 |
16 Dec 2024 | 1245 |
13 Dec 2024 | 1207.95 |
12 Dec 2024 | 1215.15 |
11 Dec 2024 | 1225.7 |
10 Dec 2024 | 1238.05 |
09 Dec 2024 | 1239.4 |
Market Cap
72,697 Cr
EPS
62.2
P/E Ratio (TTM)
19.9
P/B Ratio (TTM)
2.3
Day’s High
1274.7
Day’s Low
1235.15
DTE
0.3
ROE
11.6
52 Week High
1592.55
52 Week Low
959.05
ROCE
13.7
1M
1Y
3Y
5Y
In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at
Read more
2024-08-16 00:00:00
Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S
Read more
2024-08-16 00:00:00
Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai
Read more
2024-08-12 00:00:00
The approved drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD)
Read more
2024-08-07 00:00:00